Company Comera Life Sciences Holdings, Inc.
Equities
CMRA
US20037C1080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0292 USD | -4.72% | +38.21% | -46.73% |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| - | - | 1 | 100.0 % | - |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Campbell
CEO | Chief Executive Officer | - | 22-04-12 |
Corporate Officer/Principal | - | 22-11-08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stuart Randle
BRD | Director/Board Member | 64 | 22-05-18 |
James Sherblom
BRD | Director/Board Member | 68 | 20-12-31 |
Director/Board Member | 48 | 22-05-18 | |
Kirsten Flowers
BRD | Director/Board Member | 49 | 22-05-18 |
Edward Sullivan
BRD | Director/Board Member | - | 21-08-31 |
Dorothy Clarke
BRD | Director/Board Member | 59 | Nov. 12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,737,796 | 9,077,561 ( 29.53 %) | 0 | 29.53 % |
Stock B | 0 | 4,305 | 0 | 0 |
Company contact information
Comera Life Sciences Holdings, Inc.
12 Gill Street Suite 4650
01801, Woburn
+
http://comeralifesciences.comSector
1st Jan change | Capi. | |
---|---|---|
-46.73% | 899K | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- CMRA Stock
- Company Comera Life Sciences Holdings, Inc.